Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Protein and Peptide Letters
  4. Fast Track Articles
  5. Fast Track Article
image of Diminazene Aceturate (DIZE) Ameliorates Hypertension and Induces Anxiolytic- and Antidepressant-like Effects in TGR(mRen2)27

Abstract

Introduction

Diminazene aceturate (DIZE) was described as an angiotensin-converting enzyme 2 (ACE2) activator. ACE2/Angiotensin-(1-7)/Mas receptor axis presents protective actions on cardiovascular diseases and plays an important modulatory role in the neurobiology of mood and anxiety disorders.

Objectives

To evaluate the effects of chronic intracerebroventricular (ICV) treatment with DIZE on blood pressure, anxiety- and depression-like behaviors in hypertensive transgenic (mRen2)27 rats (TGR).

Methods

Male TGR and Sprague-Dawley rats (10-12 weeks old) were subjected to chronic ICV infusion of DIZE (1.0 µg/h for 7 days). Blood pressure and heart rate were measured by tail plethysmography and anxiety- and depression-like behaviors were evaluated through elevated plus maze, marble burying and forced swim tests, respectively.

Results

Treatment with DIZE induced a significant reduction in mean arterial pressure in both TGR and SD rats. A decrease in heart rate was only observed in the hypertensive animals. Additionally, treatment with DIZE attenuated the anxiety- and depression-like behaviors that were observed in TGR.

Conclusion

DIZE has central anti-hypertensive, anxiolytic, and anti-depressive effects.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ppl/10.2174/0109298665357730250213050214
2025-02-24
2025-05-25

  • From This Site

    /content/journals/ppl/10.2174/0109298665357730250213050214
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Donoghue M. Hsieh F. Baronas E. Godbout K. Gosselin M. Stagliano N. Donovan M. Woolf B. Robison K. Jeyaseelan R. Breitbart R.E. Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 2000 87 5 E1 E9 10.1161/01.RES.87.5.e1 10969042
    [Google Scholar]
  2. Tipnis S.R. Hooper N.M. Hyde R. Karran E. Christie G. Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000 275 43 33238 33243 10.1074/jbc.M002615200 10924499
    [Google Scholar]
  3. Patel V.B. Zhong J.C. Grant M.B. Oudit G.Y. Role of the ACE2/Angiotensin 1–7 axis of the renin–angiotensin system in heart failure. Circ. Res. 2016 118 8 1313 1326 10.1161/CIRCRESAHA.116.307708 27081112
    [Google Scholar]
  4. Santos R.A.S. Sampaio W.O. Alzamora A.C. Motta-Santos D. Alenina N. Bader M. Campagnole-Santos M.J. The ACE2/Angiotensin-(1–7)/MAS axis of the renin-angiotensin system: Focus on angiotensin-(1–7). Physiol. Rev. 2018 98 1 505 553 10.1152/physrev.00023.2016 29351514
    [Google Scholar]
  5. Verano-Braga T. Martins A.L.V. Motta-Santos D. Campagnole-Santos M.J. Santos R.A.S. ACE2 in the renin–angiotensin system. Clin. Sci. 2020 134 23 3063 3078 10.1042/CS20200478 33264412
    [Google Scholar]
  6. Mullins J.J. Peters J. Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990 344 6266 541 544 10.1038/344541a0 2181319
    [Google Scholar]
  7. Langheinrich M. Lee M.A. Böhm M. Pinto Y.M. Ganten D. Paul M. The hypertensive Ren-2 transgenic rat TGR (mREN2) 27 in hypertension research characteristics and functional aspects. Am. J. Hypertens. 1996 9 5 506 512 10.1016/0895‑7061(95)00400‑9 8735183
    [Google Scholar]
  8. Lee M.A. Böhm M. Paul M. Bader M. Ganten U. Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am. J. Physiol. Endocrinol. Metab. 1996 270 6 E919 E929 10.1152/ajpendo.1996.270.6.E919 8764174
    [Google Scholar]
  9. Bishop J. Kiernan L.A. Montgomery H.E. Gohlke P. McEwan J.R. Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats. Cardiovasc. Res. 2000 47 1 57 67 10.1016/S0008‑6363(00)00063‑8 10869530
    [Google Scholar]
  10. DeMarco V.G. Johnson M.S. Habibi J. Pulakat L. Gul R. Hayden M.R. Tilmon R.D. Dellsperger K.C. Winer N. Whaley-Connell A.T. Sowers J.R. Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat. Am. J. Physiol. Heart Circ. Physiol. 2011 300 1 H181 H190 10.1152/ajpheart.00883.2010 21057043
    [Google Scholar]
  11. Almeida-Santos A.F. Kangussu L.M. Moreira F.A. Santos R.A.S. Aguiar D.C. Campagnole-Santos M.J. Anxiolytic- and antidepressant-like effects of angiotensin-(1–7) in hypertensive transgenic (mRen2)27 rats. Clin. Sci. 2016 130 14 1247 1255 10.1042/CS20160116 27129185
    [Google Scholar]
  12. Kuriakose S. Muleme H.M. Onyilagha C. Singh R. Jia P. Uzonna J.E. Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection. PLoS One 2012 7 11 e48696 10.1371/journal.pone.0048696 23144931
    [Google Scholar]
  13. Gjymishka A Kulemina LV Shenoy V Katovich MJ Ostrov DA Raizada MK Diminazene aceturate is an ACE2 activator and a novel antihypertensive drug. FASEB J 2010 24 1032.3 1032.3 10.1096/fasebj.24.1_supplement.1032.3
    [Google Scholar]
  14. Qaradakhi T. Gadanec L.K. McSweeney K.R. Tacey A. Apostolopoulos V. Levinger I. Rimarova K. Egom E.E. Rodrigo L. Kruzliak P. Kubatka P. Zulli A. The potential actions of angiotensin‐converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases. Clin. Exp. Pharmacol. Physiol. 2020 47 5 751 758 10.1111/1440‑1681.13251 31901211
    [Google Scholar]
  15. De Maria M.L. Araújo L.D. Fraga-Silva R.A. Pereira L.A. Ribeiro H.J. Menezes G.B. Shenoy V. Raizada M.K. Ferreira A.J. Anti-hypertensive effects of diminazene aceturate: An Angiotensin- Converting enzyme 2 activator in rats. Protein Pept. Lett. 2016 23 1 9 16 10.2174/0929866522666151013130550 26458404
    [Google Scholar]
  16. Shenoy V. Gjymishka A. Jarajapu Y.P. Qi Y. Afzal A. Rigatto K. Ferreira A.J. Fraga-Silva R.A. Kearns P. Douglas J.Y. Agarwal D. Mubarak K.K. Bradford C. Kennedy W.R. Jun J.Y. Rathinasabapathy A. Bruce E. Gupta D. Cardounel A.J. Mocco J. Patel J.M. Francis J. Grant M.B. Katovich M.J. Raizada M.K. Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. Am. J. Respir. Crit. Care Med. 2013 187 6 648 657 10.1164/rccm.201205‑0880OC 23370913
    [Google Scholar]
  17. Rigatto K. Casali K.R. Shenoy V. Katovich M.J. Raizada M.K. Diminazene aceturate improves autonomic modulation in pulmonary hypertension. Eur. J. Pharmacol. 2013 713 1-3 89 93 10.1016/j.ejphar.2013.04.017 23665493
    [Google Scholar]
  18. Qi Y. Zhang J. Cole-Jeffrey C.T. Shenoy V. Espejo A. Hanna M. Song C. Pepine C.J. Katovich M.J. Raizada M.K. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 2013 62 4 746 752 10.1161/HYPERTENSIONAHA.113.01337 23959549
    [Google Scholar]
  19. Castardeli C. Sartório C.L. Pimentel E.B. Forechi L. Mill J.G. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats. Biomed. Pharmacother. 2018 107 212 218 10.1016/j.biopha.2018.07.170 30092400
    [Google Scholar]
  20. Badae N.M. El Naggar A.S. El Sayed S.M. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats? Can. J. Physiol. Pharmacol. 2019 97 7 638 646 10.1139/cjpp‑2019‑0078 30840489
    [Google Scholar]
  21. Fraga-Silva R.A. Costa-Fraga F.P. Montecucco F. Sturny M. Faye Y. Mach F. Pelli G. Shenoy V. da Silva R.F. Raizada M.K. Santos R.A.S. Stergiopulos N. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury. J. Sex. Med. 2015 12 2 289 302 10.1111/jsm.12757 25411084
    [Google Scholar]
  22. Fraga-Silva R.A. Montecucco F. Costa-Fraga F.P. Nencioni A. Caffa I. Bragina M.E. Mach F. Raizada M.K. Santos R.A.S. da Silva R.F. Stergiopulos N. Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice. Vascul. Pharmacol. 2015 74 103 113 10.1016/j.vph.2015.08.014 26304699
    [Google Scholar]
  23. Stachowicz A. Wiśniewska A. Kuś K. Białas M. Łomnicka M. Totoń-Żurańska J. Kiepura A. Stachyra K. Suski M. Bujak-Giżycka B. Jawień J. Olszanecki R. Diminazene aceturate stabilizes atherosclerotic plaque and attenuates hepatic steatosis in apoE-knockout mice by influencing macrophages polarization and taurine biosynthesis. Int. J. Mol. Sci. 2021 22 11 5861 10.3390/ijms22115861 34070749
    [Google Scholar]
  24. Coutinho D.C.O. Monnerat-Cahli G. Ferreira A.J. Medei E. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats. Europace 2014 16 11 1689 1696 10.1093/europace/euu070 24741027
    [Google Scholar]
  25. Zhang Y. Liu J. Luo J.Y. Tian X.Y. Cheang W.S. Xu J. Lau C.W. Wang L. Wong W.T. Wong C.M. Lan H.Y. Yao X. Raizada M.K. Huang Y. Upregulation of angiotensin (1-7)-mediated signaling preserves endothelial function through reducing oxidative stress in diabetes. Antioxid. Redox Signal. 2015 23 11 880 892 10.1089/ars.2014.6070 25867182
    [Google Scholar]
  26. Goru S.K. Kadakol A. Malek V. Pandey A. Sharma N. Gaikwad A.B. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT 2 receptor expression in a rat model of type1 diabetes. Br. J. Pharmacol. 2017 174 18 3118 3130 10.1111/bph.13946 28688122
    [Google Scholar]
  27. Malek M. Nematbakhsh M. The preventive effects of diminazene aceturate in renal ischemia/reperfusion injury in male and female rats. Adv. Prev. Med. 2014 2014 1 9 10.1155/2014/740647 25478235
    [Google Scholar]
  28. Silva de Almeida T.C. Lanza K. da Silva Filha R. C Campos L.M.C. Fonseca E.G. Chagas M.W. Rocha N.P. de Sá M.A. Vieira M.A.R. Caliari M.V. Kangussu L.M. Ferreira A.J. Simões E Silva A.C. ACE2 activator diminazene aceturate exerts renoprotective effects in gentamicin-induced acute renal injury in rats. Clin. Sci. 2020 134 23 3093 3106 10.1042/CS20201022 33206153
    [Google Scholar]
  29. Mecca A.P. Regenhardt R.W. O’Connor T.E. Joseph J.P. Raizada M.K. Katovich M.J. Sumners C. Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 2011 96 10 1084 1096 10.1113/expphysiol.2011.058578 21685445
    [Google Scholar]
  30. Bennion D.M. Haltigan E.A. Irwin A.J. Donnangelo L.L. Regenhardt R.W. Pioquinto D.J. Purich D.L. Sumners C. Activation of the neuroprotective angiotensin-converting enzyme 2 in rat ischemic stroke. Hypertension 2015 66 1 141 148 10.1161/HYPERTENSIONAHA.115.05185 25941346
    [Google Scholar]
  31. Kamel A.S. Abdelkader N.F. Abd El-Rahman S.S. Emara M. Zaki H.F. Khattab M.M. Stimulation of ACE2/ANG(1–7)/Mas axis by diminazene ameliorates Alzheimer’s disease in the D-Galactose-ovariectomized rat model: Role of PI3K/Akt pathway. Mol. Neurobiol. 2018 55 10 8188 8202 10.1007/s12035‑018‑0966‑3 29516284
    [Google Scholar]
  32. Duan R. Xue X. Zhang Q.Q. Wang S.Y. Gong P.Y. Yan E. Jiang T. Zhang Y.D. ACE2 activator diminazene aceturate ameliorates Alzheimer’s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice. Aging 2020 12 14 14819 14829 10.18632/aging.103544 32701063
    [Google Scholar]
  33. Evans C.E. Miners J.S. Piva G. Willis C.L. Heard D.M. Kidd E.J. Good M.A. Kehoe P.G. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathol. 2020 139 3 485 502 10.1007/s00401‑019‑02098‑6 31982938
    [Google Scholar]
  34. Sun X. Deng Y. Ge P. Peng Q. Soufiany I. Zhu L. Duan R. Diminazene ameliorates neuroinflammation by suppression of astrocytic miRNA-224-5p/NLRP3 axis in Alzheimer’s disease model. J. Inflamm. Res. 2023 16 1639 1652 10.2147/JIR.S401385 37092127
    [Google Scholar]
  35. Tiwari V. Singh J. Tiwari P. Chaturvedi S. Gupta S. Mishra A. Singh S. Wahajuddin M. Hanif K. Shukla S. ACE2/ANG-(1-7)/Mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer’s disease-like phenotypes. Eur. J. Pharmacol. 2023 946 175623 10.1016/j.ejphar.2023.175623 36871666
    [Google Scholar]
  36. Wang L. de Kloet A.D. Pati D. Hiller H. Smith J.A. Pioquinto D.J. Ludin J.A. Oh S.P. Katovich M.J. Frazier C.J. Raizada M.K. Krause E.G. Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors. Neuropharmacology 2016 105 114 123 10.1016/j.neuropharm.2015.12.026 26767952
    [Google Scholar]
  37. Nakagawasai O. Takahashi K. Koyama T. Yamagata R. Nemoto W. Tan-No K. Activation of angiotensin-converting enzyme 2 produces an antidepressant-like effect via MAS receptors in mice. Mol. Brain 2023 16 1 52 10.1186/s13041‑023‑01040‑y 37312182
    [Google Scholar]
  38. Paxinos G. Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed 2007
    [Google Scholar]
  39. Krege J.H. Hodgin J.B. Hagaman J.R. Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995 25 5 1111 1115 10.1161/01.HYP.25.5.1111 7737724
    [Google Scholar]
  40. Handley S.L. Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of? fear?-motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 1984 327 1 1 5 10.1007/BF00504983 6149466
    [Google Scholar]
  41. Walf A.A. Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007 2 2 322 328 10.1038/nprot.2007.44 17406592
    [Google Scholar]
  42. Amado Costa L. Amaral L.B.O. Mourão F.A.G. Bader M. Santos R.A.S. Campagnole-Santos M.J. Kangussu L.M. Anxiolytic effect of alamandine in male transgenic rats with low brain angiotensinogen is dependent on activation of MrgD receptors. Horm. Behav. 2024 163 105551 10.1016/j.yhbeh.2024.105551 38678724
    [Google Scholar]
  43. El Marzouki H. Aboussaleh Y. Najimi M. Chigr F. Ahami A. Effect of cold stress on neurobehavioral and physiological parameters in rats. Front. Physiol. 2021 12 660124 10.3389/fphys.2021.660124 34603068
    [Google Scholar]
  44. Colla A.R.S. Rosa J.M. Cunha M.P. Rodrigues A.L.S. Anxiolytic-like effects of ursolic acid in mice. Eur. J. Pharmacol. 2015 758 171 176 10.1016/j.ejphar.2015.03.077 25861934
    [Google Scholar]
  45. Sartim A.G. Sartim M.A. Cummings R.D. Dias-Baruffi M. Joca S.R. Impaired emotional response to stress in mice lacking galectin-1 or galectin-3. Physiol. Behav. 2020 220 112862 10.1016/j.physbeh.2020.112862 32156558
    [Google Scholar]
  46. Porsolt R.D. Le Pichon M. Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature 1977 266 5604 730 732 10.1038/266730a0 559941
    [Google Scholar]
  47. Cryan J.F. Valentino R.J. Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci. Biobehav. Rev. 2005 29 4-5 547 569 10.1016/j.neubiorev.2005.03.008 15893822
    [Google Scholar]
  48. Kangussu L.M. Almeida-Santos A.F. Bader M. Alenina N. Fontes M.A.P. Santos R.A.S. Aguiar D.C. Campagnole-Santos M.J. Angiotensin-(1-7) attenuates the anxiety and depression-like behaviors in transgenic rats with low brain angiotensinogen. Behav. Brain Res. 2013 257 25 30 10.1016/j.bbr.2013.09.003 24016839
    [Google Scholar]
  49. Almeida-Santos A.F. de Melo L.A. Gonçalves S.C.A. Oliveira Amaral L.B. Santos R.A.S. Campagnole-Santos M.J. Kangussu L.M. Alamandine through MrgD receptor induces antidepressant-like effect in transgenic rats with low brain angiotensinogen. Horm. Behav. 2021 127 104880 10.1016/j.yhbeh.2020.104880 33129833
    [Google Scholar]
  50. Abel E.L. Bilitzke P.J. A possible alarm substance in the forced swimming test. Physiol. Behav. 1990 48 2 233 239 10.1016/0031‑9384(90)90306‑O 2255725
    [Google Scholar]
  51. Porsolt R.D. Bertin A. Jalfre M. “Behavioural despair” in rats and mice: Strain differences and the effects of imipramine. Eur. J. Pharmacol. 1978 51 3 291 294 10.1016/0014‑2999(78)90414‑4 568552
    [Google Scholar]
  52. Slattery D.A. Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 2012 7 6 1009 1014 10.1038/nprot.2012.044 22555240
    [Google Scholar]
  53. Bader M. Zhao Y. Sander M. Lee M.A. Bachmann J. Böhm M. Djavidani B. Peters J. Mullins J.J. Ganten D. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats. Hypertension 1992 19 6_pt_2 681 686 10.1161/01.HYP.19.6.681 1592468
    [Google Scholar]
  54. Kangussu L.M. Guimaraes P.S. Nadu A.P. Melo M.B. Santos R.A.S. Campagnole-Santos M.J. Activation of angiotensin-(1–7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Neuropharmacology 2015 97 58 66 10.1016/j.neuropharm.2015.04.036 25983274
    [Google Scholar]
  55. Velkoska E. Patel S.K. Burrell L.M. Angiotensin converting enzyme 2 and diminazene. Curr. Opin. Nephrol. Hypertens. 2016 25 5 384 395 10.1097/MNH.0000000000000254 27367913
    [Google Scholar]
  56. Kangussu L.M. de Almeida T.C.S. Prestes T.R.R. de Andrade De Maria M.L. da Silva Filha R. Vieira M.A.R. Silva A.C.S. Ferreira A.J. Beneficial effects of the angiotensin-converting enzyme 2 activator dize in renovascular hypertension. Protein Pept. Lett. 2019 26 7 523 531 10.2174/0929866526666190405123422 30950337
    [Google Scholar]
  57. Zhang C. Cao X. Wang H. Li Z. Zhang Y. The ACE2 activator diminazene aceturate ameliorates colitis by repairing the gut-vascular barrier in mice. Microvasc. Res. 2023 148 104544 10.1016/j.mvr.2023.104544 37127063
    [Google Scholar]
  58. Passaglia P. Kanashiro A. Batista Silva H. Navegantes L.C.C. Lacchini R. Cárnio C.E. Branco L.G.S. Diminazene aceturate attenuates systemic inflammation via microbiota gut-5-HT brain-spleen sympathetic axis in male mice. Brain Behav. Immun. 2024 119 105 119 10.1016/j.bbi.2024.03.037 38548186
    [Google Scholar]
  59. Sartório C.L. Pimentel E.B. dos Santos R.L. Rouver W.N. Mill J.G. Acute hypotensive effect of diminazene aceturate in spontaneously hypertensive rats: Role of NO and Mas receptor. Clin. Exp. Pharmacol. Physiol. 2020 47 10 1723 1730 10.1111/1440‑1681.13368 32603499
    [Google Scholar]
  60. Bessa A.S.M. Jesus É.F. Nunes A.D.C. Pontes C.N.R. Lacerda I.S. Costa J.M. Souza E.J. Lino-Júnior R.S. Biancardi M.F. dos Santos F.C.A. Pedrino G.R. Colugnati D.B. Mazaro-Costa R. Mendes E.P. Castro C.H. Stimulation of the ACE2/Ang-(1–7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring. Hypertens. Res. 2019 42 12 1883 1893 10.1038/s41440‑019‑0321‑8 31506648
    [Google Scholar]
  61. de Kloet A.D. Cahill K.M. Scott K.A. Krause E.G. Overexpression of angiotensin converting enzyme 2 reduces anxiety-like behavior in female mice. Physiol. Behav. 2020 224 113002 10.1016/j.physbeh.2020.113002 32525008
    [Google Scholar]
  62. Atsriku C. Watson D.G. Tettey J.N.A. Grant M.H. Skellern G.G. Determination of diminazene aceturate in pharmaceutical formulations by HPLC and identification of related substances by LC/MS. J. Pharm. Biomed. Anal. 2002 30 4 979 986 10.1016/S0731‑7085(02)00450‑8 12408888
    [Google Scholar]
  63. Dutra J.B.R. Lacerda I.S. Nunes A.D.C. Bessa A.S.M. Jesus É.F. Pontes C.N.R. Naves L.M. Pedrino G.R. Mendes E.P. Fraga-Silva R.A. Costa-Fraga F.P. Stergiopulos N. Kangussu L.M. Faraco A.A.G. Ferreira A.J. Castro C.H. p-Aminobenzamidine attenuates cardiovascular dysfunctions in spontaneously hypertensive rats. Life Sci. 2022 304 120693 10.1016/j.lfs.2022.120693 35688180
    [Google Scholar]
  64. Haber P.K. Ye M. Wysocki J. Maier C. Haque S.K. Batlle D. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: Studies in vivo, ex vivo, and in vitro. Hypertension 2014 63 4 774 782 10.1161/HYPERTENSIONAHA.113.02856 24446061
    [Google Scholar]
/content/journals/ppl/10.2174/0109298665357730250213050214
Loading
Diminazene Aceturate (DIZE) Ameliorates Hypertension and Induces Anxiolytic- and Antidepressant-like Effects in TGR(mRen2)27
Bentham Science Publishers ; https://doi.org/10.2174/0109298665357730250213050214
/content/journals/ppl/10.2174/0109298665357730250213050214
/content/journals/ppl/10.2174/0109298665357730250213050214
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: depression ; Diminazene aceturate ; anxiety ; TGR(mRen2)27 ; hypertension ; ACE2

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test